Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Ventas, Inc.

VTR · NYSE · CIK 0000740260 · Real Estate · REIT—Healthcare Facilities

INSIDER SIGNAL

40.0 / 100

1 buyers · 1 purchase transaction lines · $197.0K gross purchase

WHY THIS SIGNAL?

Buyer breadthLow
Purchase sizeLow
RoleStrong
RecencyLow
ConvictionModerate
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+7.0 / 35
Purchase size+7.2 / 25
Role+20.0 / 20
Recency+1.0 / 10
Conviction+4.7 / 10

What is holding the score back?

  • ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
  • ⚠ Purchase size is modest relative to the model scale
  • ⚠ Purchase activity is becoming less recent
  • ⚠ Buying conviction is reduced by concurrent selling
  • ✓ Role scores high · most senior buyer: Director

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Smith Maurice SDirector
○○○○○○○
Martino Roxanne MDirector
○○○○○○○
Roy SumitDirector
○○○○○
LUSTIG MATTHEW JDirector
○○○○○
EMBLER MICHAEL JDirector
○●○○
Rodriguez Joe Vasquez Jr.Director
○○○
● Purchase▼ Sale○ Other

Showing the six most active owners; 8 additional owner(s) remain in Form 4 evidence.

Purchase breadth & concentration

QUALIFYING BUYERS1
PURCHASE CONCENTRATION100%Largest buyer: EMBLER MICHAEL J · $197.0K
CLUSTER BUYING · 15D1 insiderPeak activity: 2026-06-03–2026-06-03

Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

40.0 / 100

Latest recorded score

→ +0.0 ptsversus the previous recorded snapshot
  1. 40.2
  2. 40.1
  3. 40.1
  4. 40.0
  5. 40.0

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

1Purchases
26Sales
133Other Form 4 lines
90SEC filings · 365 days
BUYING1 qualifying P line(s) · 180 days
SELLING1 sale line(s) · context only
OTHER51 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot detected in parsed evidence

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
-9.3%
3M
-10.9%
6M
-3.4%
12M
+20.6%

Volatility & liquidity

Volatility
22.3%
Beta
—
Avg daily value
USD 287.6M

Valuation

Market cap
USD 42.1B
P/E
160.9×

Fundamentals

Profit margin
4.5%
ROE
2.1%
Industry
REIT—Healthcare Facilities

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, P/E, Profit margin, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-07-28 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
16,501,695
Previous report
19,779,274
Avg daily volume
4,236,225
Days to cover
3.9

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-03EMBLER MICHAEL JPurchase (P)Common Stock2,500USD 78.81USD 197,025SEC filing ↗
2020-07-21Nolan Sean P.Purchase (P)Common Stock64USD 34.21USD 2,189SEC filing ↗
2020-04-20Nolan Sean P.Purchase (P)Common Stock86USD 27.70USD 2,382SEC filing ↗

Form 4 evidence

160 transaction lines in the latest 365-day window; 881 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-15Smith Maurice SAward / grant (A)Common Stock147USD 84.86USD 12,453SEC filing ↗
2026-10-15Roy SumitAward / grant (A)Common Stock136USD 84.86USD 11,524SEC filing ↗
2026-10-15Rodriguez Joe Vasquez Jr.Award / grant (A)Common Stock55USD 84.86USD 4,636SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-15Smith Maurice SAward / grant (A)Common Stock147USD 84.86USD 12,453SEC filing ↗
2026-10-15Roy SumitAward / grant (A)Common Stock136USD 84.86USD 11,524SEC filing ↗
2026-10-15Rodriguez Joe Vasquez Jr.Award / grant (A)Common Stock55USD 84.86USD 4,636SEC filing ↗
2026-10-15NADER MARGUERITE MAward / grant (A)Common Stock81USD 84.86USD 6,844SEC filing ↗
2026-10-15Martino Roxanne MAward / grant (A)Common Stock199USD 84.86USD 16,899SEC filing ↗
2026-10-15LUSTIG MATTHEW JAward / grant (A)Common Stock319USD 84.86USD 27,112SEC filing ↗
2026-10-15EMBLER MICHAEL JAward / grant (A)Common Stock81USD 84.86USD 6,844SEC filing ↗
2026-10-15Barnes Melody CAward / grant (A)Common Stock81USD 84.86USD 6,844SEC filing ↗
2026-10-13Smith Maurice SAward / grant (A)Common Stock18USD 83.85USD 1,500SEC filing ↗
2026-10-13Martino Roxanne MAward / grant (A)Common Stock18USD 83.85USD 1,500SEC filing ↗
2026-10-06Smith Maurice SAward / grant (A)Common Stock18USD 81.86USD 1,500SEC filing ↗
2026-10-06Martino Roxanne MAward / grant (A)Common Stock18USD 81.86USD 1,500SEC filing ↗
2026-10-05Sayed LauridaAward / grant (A)Common Stock4,301USD 81.36USD 349,929SEC filing ↗
2026-10-01Smith Maurice SAward / grant (A)Common Stock478USD 83.73USD 40,000SEC filing ↗
2026-10-01Roy SumitAward / grant (A)Common Stock373USD 83.73USD 31,250SEC filing ↗
2026-10-01Martino Roxanne MAward / grant (A)Common Stock582USD 83.73USD 48,750SEC filing ↗
2026-10-01LUSTIG MATTHEW JAward / grant (A)Common Stock448USD 83.73USD 37,500SEC filing ↗
2026-08-01Wattula AndyAward / grant (A)Common Stock15,008USD 93.51USD 1,403,398SEC filing ↗
2026-07-16Smith Maurice SAward / grant (A)Common Stock128USD 95.04USD 12,148SEC filing ↗
2026-07-16Roy SumitAward / grant (A)Common Stock119USD 95.04USD 11,282SEC filing ↗
2026-07-16Rodriguez Joe Vasquez Jr.Award / grant (A)Common Stock49USD 95.04USD 4,610SEC filing ↗
2026-07-16NADER MARGUERITE MAward / grant (A)Common Stock72USD 95.04USD 6,807SEC filing ↗
2026-07-16Martino Roxanne MAward / grant (A)Common Stock174USD 95.04USD 16,527SEC filing ↗
2026-07-16LUSTIG MATTHEW JAward / grant (A)Common Stock281USD 95.04USD 26,734SEC filing ↗
2026-07-16EMBLER MICHAEL JAward / grant (A)Common Stock72USD 95.04USD 6,807SEC filing ↗
2026-07-16Barnes Melody CAward / grant (A)Common Stock72USD 95.04USD 6,807SEC filing ↗
2026-07-01Smith Maurice SAward / grant (A)Common Stock461USD 89.65USD 41,319SEC filing ↗
2026-07-01Roy SumitAward / grant (A)Common Stock349USD 89.65USD 31,250SEC filing ↗
2026-07-01Martino Roxanne MAward / grant (A)Common Stock544USD 89.65USD 48,750SEC filing ↗
2026-07-01LUSTIG MATTHEW JAward / grant (A)Common Stock448USD 89.65USD 40,137SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerVTR
CIK0000740260
SectorReal Estate
IndustryREIT—Healthcare Facilities Yahoo Finance
SEC SIC6798 Real Estate Investment Trusts
ExchangeNYSE

Data coverage

Local Form 4 history881 transaction lines from 2020-01-01 to 2026-10-15
5 P purchase lines · 108 S sale lines · 768 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.